140 results
Page 6 of 7
6-K
EX-99.1
dfqbr
30 Oct 14
Teva Reports Third Quarter 2014 Results
12:00am
6-K
wqzzq5w2h k22
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
6984oq29ftg91e1e
8 Oct 14
Live Filing
12:00am
6-K
EX-99.1
t7ijfve5674smc 4d
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
ta7tafich5yweq62gqo
12 Sep 14
Teva Presents Gene Expression Analysis at Joint ACTRIMS-ECTRIMS Meeting Demonstrating COPAXONE® (glatiramer acetate injection) Has a Complex Profile
12:00am
6-K
EX-99.1
k56vs3e gitmhenvck
12 Sep 14
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
12:00am
6-K
EX-99.1
hcajc1
11 Sep 14
Live Filing
12:00am
6-K
EX-99.1
aegpnld9k91
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
EX-99.1
ou7u20jjhzvz4rfo
4 Sep 14
Teva Announces Launch of Generic Baraclude® TABLETS,0.5MG and 1MG, In the United States
12:00am
6-K
EX-99.1
jiuvyl6qqb
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
9ckiw8h wr
3 Sep 14
Teva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZeneca
12:00am
6-K
EX-99.1
zt2tgz461b2ht9duk
3 Sep 14
Live Filing
12:00am
6-K
EX-99.1
oyc4rus4vj6gur90j
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
6qr1qmjeygv3r5ysbj3e
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am
6-K
EX-99.1
czz 8jaqmv254oa8
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
jjzw51
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
59m486k
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
w9iudlg1 4mqui33n
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
6-K
EX-99.1
slg4yv9 awbu
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
23yofd3 k9ix0h
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am